Okay on topic, a little break down for new investors: IS this better Kgem
Some have questioned if UNVC was ever on the NASDAQ. Here is, page 43.
https://www.finra.org/sites/default/files/Cor...009761.pdf
Nasdaq Initial Public Offerings for 1997.
CHECK this --- Set forth below are the high and low closing sale prices for the Common Stock and Warrants on the Nasdaq SmallCap Market for each quarter since April 24, 1997.
("UNVC" ("UNVCW"
Quarter Ended High Low High Low
June 30, 1997 (since April 24, 1997) ............ $ 10.125 $ 1.625 $ 7.688 $ 0.438
September 30, 1997 .............................. $ 4.438 $ 1.500 $ 1.750 $ 0.313
December 31, 1997 ............................... $ 2.500 $ 1.125 $ 0.813 $ 0.219
March 31, 1998 (through March 27, 1998) ......... $ 1.875 $ 1.375 $ 0.625 $ 0.219
https://www.marketwatch.com/investing/stock/U...;type=0000
If you want to read the full story about the raw deal that happened to Univec and their syringe business, here it is. It will take a while to read the entire story, but it lays everything out pretty darn well. In my opinion, the read is well worth the time and effort. Keep in mind this story lays out only the primary facts and does not detail all the dirty tricks done by Beckton Dickinson, the WHO, UNICEF and others involved in this travesty. The result is many thousands of people died and suffered from unnecessary illnesses because of unsanitary needles.
https://www.sfgate.com/health/article/DEADLY-...982292.php
BY BOE RIMES ON FEBRUARY 13, 2021
https://microcapdaily.com/major-run-on-unvc-u...nc/130397/
There is a lot to get excited about on UNVC which has been rising dramatically thanks to a low float and a tightly held stock structure that’s just not selling. The Company is led by Dr. David Dalton, the first black pharmaceutical executive in the chain drug industry and he has assembled an impressive BOD including John C. Peoples, Past Vice President of Merck and Kennneth Grant past Vice President of Johns Hopkins Health System. UNVC is developing the gold standard certified Transdermal CBD Patch and Opioid withdrawal solution that will be distributed WORLDWIDE after years of clinical trials and now a grow facility belonging to the Company’s conglomerate in Israel. The Company has partnerships with Harvest (HRVSF), RITE AID, Walmart, PPSI and Wellness Teladoc subsidiaries and Big Pharma most likely Merck as they were in Israel watching our clinical trials closely.
UNVC is currently working with Euromed to corner Europe’s medical MJ market and Medicaid telemedicine and Medicare in America. The Company also recently stated it plans to up list to a major exchange (Nasdaq) in the first quarter of 2021 (only a few weeks left of this quarter). Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005 reporting at the time: “UNIVEC, Inc. (OTCMKTS: UNVC) has been running up the charts in recent months from a start point in triple zero land to recent highs of $0.0076. The stock has quickly attracted a large shareholder base which has been bidding this one higher.” Shareholders have stated concerns about UNVC's lack of filings or recent press releases --- All of which are valid concerns. However, CEO David Dalton stated on LinkedIn and twitter we are all on track to be fully reporting and Nasdaq by the end of this quarter.
A reminder to help keep spirits up from Twitter:
David Dalton
David Dalton
• 3rd+
CHAIRMAN,PRES,CEO UNIVEC CONGLOMERATE INC. (UNVC)
1w • 1 week ago
Believe--- All my life a better Place - working hard everyday
Giving everyone a better opportunity- Color is Green-
Most important is the Human Being that wants a better life.
Failure is not in my DNA . Nothing will stop our Success
Book it
Dr. David Dalton has been working with Johns Hopkins medical to treat opioid addiction, and Dalton has been supplying Johns Hopkins with pre-loaded methadone to aid this treatment. This was stated at the last IFAH conference. Here is a little more data:
Cardinal Health
Farmingdale, USA-based Univec, a supplier of patented safety syringes,medical waste disposal systems, and drug sampling programs for pharmaceutical companies, announced that its safety products are being distributed by Allegiance Healthcare Corp.
Allegiance is a subsidiary of Cardinal Health, a leading provider of products and services supporting the health care industry with annual revenues of more than $40 billion. David Dalton, chief executive of Univec, said that "having Univec products stocked for distribution by reputable vendors such as Allegiance is key to supporting our domestic sales supply chain and promoting Univec's unique safety brand." He added that "Univec has become more than a syringe company, and this agreement is another step in its evolution toward becoming a specialty pharmaceutical company that remains focused on safety."
Univec Announces Completion Of Vista-Pharm Joint Venture
Published: Apr 08, 2005
BALTIMORE--(BUSINESS WIRE)--April 7, 2005--Univec, Inc. (OTCBB: UNVC) a pharmaceutical, pre-filled and safety syringe healthcare organization announces joint venture completed with Vista-Pharm. David L. Dalton, President and CEO of Univec stated, "Completion of this joint venture with Vista-Pharm adds to Univec's portfolio of products and services that fits our business model. We anticipate continuing to expand production and diversity of product to sure up profitability. Vista-Pharm's Methadone line of products as well as other difficult and highly regulated pharmaceuticals adds to the value of the Univec brand."
Might add more to it a littler later
TOODLES
Some have questioned if UNVC was ever on the NASDAQ. Here is, page 43.
https://www.finra.org/sites/default/files/Cor...009761.pdf
Nasdaq Initial Public Offerings for 1997.
CHECK this --- Set forth below are the high and low closing sale prices for the Common Stock and Warrants on the Nasdaq SmallCap Market for each quarter since April 24, 1997.
("UNVC" ("UNVCW"
Quarter Ended High Low High Low
June 30, 1997 (since April 24, 1997) ............ $ 10.125 $ 1.625 $ 7.688 $ 0.438
September 30, 1997 .............................. $ 4.438 $ 1.500 $ 1.750 $ 0.313
December 31, 1997 ............................... $ 2.500 $ 1.125 $ 0.813 $ 0.219
March 31, 1998 (through March 27, 1998) ......... $ 1.875 $ 1.375 $ 0.625 $ 0.219
https://www.marketwatch.com/investing/stock/U...;type=0000
If you want to read the full story about the raw deal that happened to Univec and their syringe business, here it is. It will take a while to read the entire story, but it lays everything out pretty darn well. In my opinion, the read is well worth the time and effort. Keep in mind this story lays out only the primary facts and does not detail all the dirty tricks done by Beckton Dickinson, the WHO, UNICEF and others involved in this travesty. The result is many thousands of people died and suffered from unnecessary illnesses because of unsanitary needles.
https://www.sfgate.com/health/article/DEADLY-...982292.php
BY BOE RIMES ON FEBRUARY 13, 2021
https://microcapdaily.com/major-run-on-unvc-u...nc/130397/
There is a lot to get excited about on UNVC which has been rising dramatically thanks to a low float and a tightly held stock structure that’s just not selling. The Company is led by Dr. David Dalton, the first black pharmaceutical executive in the chain drug industry and he has assembled an impressive BOD including John C. Peoples, Past Vice President of Merck and Kennneth Grant past Vice President of Johns Hopkins Health System. UNVC is developing the gold standard certified Transdermal CBD Patch and Opioid withdrawal solution that will be distributed WORLDWIDE after years of clinical trials and now a grow facility belonging to the Company’s conglomerate in Israel. The Company has partnerships with Harvest (HRVSF), RITE AID, Walmart, PPSI and Wellness Teladoc subsidiaries and Big Pharma most likely Merck as they were in Israel watching our clinical trials closely.
UNVC is currently working with Euromed to corner Europe’s medical MJ market and Medicaid telemedicine and Medicare in America. The Company also recently stated it plans to up list to a major exchange (Nasdaq) in the first quarter of 2021 (only a few weeks left of this quarter). Microcapdaily first reported on UNVC on October 28, 2018 when the stock was around $0.005 reporting at the time: “UNIVEC, Inc. (OTCMKTS: UNVC) has been running up the charts in recent months from a start point in triple zero land to recent highs of $0.0076. The stock has quickly attracted a large shareholder base which has been bidding this one higher.” Shareholders have stated concerns about UNVC's lack of filings or recent press releases --- All of which are valid concerns. However, CEO David Dalton stated on LinkedIn and twitter we are all on track to be fully reporting and Nasdaq by the end of this quarter.
A reminder to help keep spirits up from Twitter:
David Dalton
David Dalton
• 3rd+
CHAIRMAN,PRES,CEO UNIVEC CONGLOMERATE INC. (UNVC)
1w • 1 week ago
Believe--- All my life a better Place - working hard everyday
Giving everyone a better opportunity- Color is Green-
Most important is the Human Being that wants a better life.
Failure is not in my DNA . Nothing will stop our Success
Book it
Dr. David Dalton has been working with Johns Hopkins medical to treat opioid addiction, and Dalton has been supplying Johns Hopkins with pre-loaded methadone to aid this treatment. This was stated at the last IFAH conference. Here is a little more data:
Cardinal Health
Farmingdale, USA-based Univec, a supplier of patented safety syringes,medical waste disposal systems, and drug sampling programs for pharmaceutical companies, announced that its safety products are being distributed by Allegiance Healthcare Corp.
Allegiance is a subsidiary of Cardinal Health, a leading provider of products and services supporting the health care industry with annual revenues of more than $40 billion. David Dalton, chief executive of Univec, said that "having Univec products stocked for distribution by reputable vendors such as Allegiance is key to supporting our domestic sales supply chain and promoting Univec's unique safety brand." He added that "Univec has become more than a syringe company, and this agreement is another step in its evolution toward becoming a specialty pharmaceutical company that remains focused on safety."
Univec Announces Completion Of Vista-Pharm Joint Venture
Published: Apr 08, 2005
BALTIMORE--(BUSINESS WIRE)--April 7, 2005--Univec, Inc. (OTCBB: UNVC) a pharmaceutical, pre-filled and safety syringe healthcare organization announces joint venture completed with Vista-Pharm. David L. Dalton, President and CEO of Univec stated, "Completion of this joint venture with Vista-Pharm adds to Univec's portfolio of products and services that fits our business model. We anticipate continuing to expand production and diversity of product to sure up profitability. Vista-Pharm's Methadone line of products as well as other difficult and highly regulated pharmaceuticals adds to the value of the Univec brand."
Might add more to it a littler later
TOODLES
4
